Evidence map›Paper›PMID 32385370›Full record

ArticleScientific reports2020

Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.

Visalini Nair-Shalliker, Albert Bang, Sam Egger, Mark Clements, Robert A Gardiner, Anne Kricker, Markus J Seibel, Suzanne K Chambers, Michael G Kimlin, Bruce K Armstrong and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Vitamin D deficiency: a potential risk factor for cancer in obesity?International journal of obesity (2005) · 2022
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Visalini Nair-ShallikerCancer Research Division, Cancer Council NSW, Sydney, NSW, Australia. visalinin@nswcc.org.au.ORCID http://orcid.org/0000-0001-6277-5125
Albert BangCancer Research Division, Cancer Council NSW, Sydney, NSW, Australia.
Sam EggerCancer Research Division, Cancer Council NSW, Sydney, NSW, Australia.
Mark ClementsKarolinka Institute, Stockholm, Sweden.
Robert A GardinerUniversity of Queensland, Brisbane, Australia.
Anne KrickerSydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Markus J SeibelBone Research Program, ANZAC Research Institute, and Concord Medical School, The University of Sydney, Sydney, Australia.
Suzanne K ChambersFaculty of Management, University Technology of Sydney, Sydney, Australia.
Michael G KimlinHealth Research Institute, University of the Sunshine Coast, Queensland, Australia.
Bruce K ArmstrongCancer Research Division, Cancer Council NSW, Sydney, NSW, Australia.
David P SmithCancer Research Division, Cancer Council NSW, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-1474-3214
The University of Sydney · AUCancer Council NSW · AUUniversity of Technology Sydney · AUKarolinska Institutet · SEThe University of Queensland · AUThe University of Western Australia · AUUniversity of the Sunshine Coast · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D may reduce mortality from prostate cancer (PC). We examined the associations of post-treatment plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with PC mortality. Participants were PC cases from the New South Wales Prostate Cancer Care. All contactable and consenting participants, at 4.9 to 8.6 years after diagnosis, were interviewed and had plasma 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)

Indexed as

AgedDihydroxycholecalciferolsHumansMaleMiddle AgedProstatic NeoplasmsSurvival AnalysisVitamin D25-hydroxyvitamin DDihydroxycholecalciferolsVitamin D

Identifiers

PMID32385370
PMCPMC7210996
OpenAlexW3023679787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.